Finley John David 4
4 · PALISADE BIO, INC. · Filed Oct 8, 2025
Insider Transaction Report
Form 4
Finley John David
DirectorCEO, CFO
Transactions
- Award
Restricted Stock Units
2025-10-06+9,179,400→ 9,179,400 total→ Common Stock (9,179,400 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash.
- [F2]The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.